Gabapentin inhibits catecholamine release from adrenal chromaffin cells

Anesthesiology

Volumn 116, Issue 5, 2012, Pages 1013-1024

  Todd, Robert D ^a   McDavid, Sarah M ^a   Brindley, Rebecca L ^a   Jewell, Mark L ^a   Currie, Kevin P M ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CATECHOLAMINE; GABAPENTIN; VOLTAGE GATED CALCIUM CHANNEL;

AMPEROMETRY; ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CATECHOLAMINE RELEASE; CHROMAFFIN CELL; COW; DRUG EFFECT; EXOCYTOSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NONHUMAN; PRIORITY JOURNAL;

ADRENAL GLANDS; AMINES; ANIMALS; CALCIUM; CALCIUM CHANNELS; CALCIUM SIGNALING; CATECHOLAMINES; CATTLE; CHOLINERGIC AGONISTS; CHROMAFFIN CELLS; CYCLOHEXANECARBOXYLIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; HEMODYNAMICS; PATCH-CLAMP TECHNIQUES; POTASSIUM CHLORIDE; SECRETORY VESICLES;

EID: 84860775897     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e31825153ea     Document Type: Article

References (65)

1. Kong VK, Irwin MG: Gabapentin: A multimodal perioperative drug? Br J Anaesth 2007; 99:775-86
2. Fassoulaki A, Melemeni A, Paraskeva A, Petropoulos G: Gabapentin attenuates the pressor response to direct laryngoscopy and tracheal intubation. Br J Anaesth 2006; 96:769-73
3. Memis D, Turan A, Karamanlioǧlu B, Seker S, Türe M: Gabapentin reduces cardiovascular responses to laryngoscopy and tracheal intubation. Eur J Anaesthesiol 2006; 23:686-90
4. Derbyshire DR, Chmielewski A, Fell D, Vater M, Achola K, Smith G: Plasma catecholamine responses to tracheal intubation. Br J Anaesth 1983; 55:855-60
5. Shribman AJ, Smith G, Achola KJ: Cardiovascular and catecholamine responses to laryngoscopy with and without tracheal intubation. Br J Anaesth 1987; 59:295-9
6. Brossy MJ, James MF, Janicki PK: Haemodynamic and catecholamine changes after induction of anaesthesia with either thiopentone or propofol with suxamethonium. Br J Anaesth 1994; 72:596-8
7. Russell WJ, Morris RG, Frewin DB, Drew SE: Changes in plasma catecholamine concentrations during endotracheal intubation. Br J Anaesth 1981; 53:837-9
8. Taylor CP: Mechanisms of analgesia by gabapentin and pregabalin-calcium channel alpha2-delta [Cavalpha2-delta] ligands. Pain 2009; 142:13-6
9. Di Guilmi MN, Urbano FJ, Inchauspe CG, Uchitel OD: Pregabalin modulation of neurotransmitter release is mediated by change in intrinsic activation/inactivation properties of ca(v)2.1 calcium channels. J Pharmacol Exp Ther 2011; 336:973-82
10. Stefani A, Spadoni F, Bernardi G: Gabapentin inhibits calcium currents in isolated rat brain neurons. Neuropharmacology 1998; 37:83-91
11. Sutton KG, Martin DJ, Pinnock RD, Lee K, Scott RH: Gabapentin inhibits high-threshold calcium channel currents in cultured rat dorsal root ganglion neurones. Br J Pharmacol 2002; 135:257-65
12. Martin DJ, McClelland D, Herd MB, Sutton KG, Hall MD, Lee K, Pinnock RD, Scott RH: Gabapentin-mediated inhibition of voltage-activated Ca2+ channel currents in cultured sensory neurones is dependent on culture conditions and channel subunit expression. Neuropharmacology 2002; 42:353-66
13. Mich PM, Horne WA: Alternative splicing of the Ca2+ channel beta4 subunit confers specificity for gabapentin inhibition of Cav2.1 trafficking. Mol Pharmacol 2008; 74:904-12
14. Hendrich J, Van Minh AT, Heblich F, Nieto-Rostro M, Watschinger K, Striessnig J, Wratten J, Davies A, Dolphin AC: Phar-macological disruption of calcium channel trafficking by the alpha2 delta ligand gabapentin. Proc Natl Acad Sci USA 2008; 105:3628-33
15. Vega-Hernández A, Felix R: Down-regulation of N-type voltage-activated Ca2+ channels by gabapentin. Cell Mol Neurobiol 2002; 22:185-90
16. Heblich F, Tran Van Minh A, Hendrich J, Watschinger K, Dolphin AC: Time course and specificity of the pharmacological disruption of the trafficking of voltage-gated calcium channels by gabapentin. Channels (Austin) 2008; 2:4-9
17. Tran-Van-Minh A, Dolphin AC: The alpha2delta ligand gabapentin inhibits the Rab11-dependent recycling of the calcium channel subunit alpha2delta-2. J Neurosci 2010; 30: 12856-67
18. Micheva KD, Taylor CP, Smith SJ: Pregabalin reduces the release of synaptic vesicles from cultured hippocampal neurons. Mol Pharmacol 2006; 70:467-76
19. Cunningham MO, Woodhall GL, Thompson SE, Dooley DJ, Jones RS: Dual effects of gabapentin and pregabalin on glutamate release at rat entorhinal synapses in vitro. Eur J Neurosci 2004; 20:1566-76
20. Bader MF, Holz RW, Kumakura K, Vitale N: Exocytosis: The chromaffin cell as a model system. Ann N Y Acad Sci 2002; 971:178-83
21. Currie KP: Inhibition of Ca2+ channels and adrenal catecholamine release by G protein coupled receptors. Cell Mol Neurobiol 2010; 30:1201-8
22. Borges R, Camacho M, Gillis KD: Measuring secretion in chromaffin cells using electrophysiological and electrochemical methods. Acta Physiol (Oxf) 2008; 192:173-84
23. Viveros OH, Wilson SP: The adrenal chromaffin cell as a model to study the co-secretion of enkephalins and catecholamines. J Auton Nerv Syst 1983; 7:41-58
24. Khasar SG, Dina OA, Green PG, Levine JD: Sound stressinduced long-term enhancement of mechanical hyperalgesia in rats is maintained by sympathoadrenal catecholamines. J Pain 2009; 10:1073-7
25. Dzhura EV, He W, Currie KP: Linopirdine modulates calcium signaling and stimulus-secretion coupling in adrenal chromaffin cells by targeting M-type K+ channels and nicotinic acetylcholine receptors. J Pharmacol Exp Ther 2006; 316:1165-74
26. Mosharov EV, Sulzer D: Analysis of exocytotic events recorded by amperometry. Nat Methods 2005; 2:651-8
27. Yadid G, Youdim MB, Zinder O: Preferential release of epinephrine by glycine from adrenal chromaffin cells. Eur J Pharmacol 1992; 221:389-91
28. Cahill AL, Perlman RL: Phorbol esters cause preferential secretion of norepinephrine from bovine chromaffin cells. J Neurochem 1992; 58:768-71
29. Fulop T, Smith C: Matching native electrical stimulation by graded chemical stimulation in isolated mouse adrenal chromaffin cells. J Neurosci Methods 2007; 166:195-202
30. Gee NS, Brown JP, Dissanayake VU, Offord J, Thurlow R, Woodruff GN: The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel. J Biol Chem 1996; 271:5768-76
31. Currie KP, Fox AP: ATP serves as a negative feedback inhibitor of voltage-gated Ca2+ channel currents in cultured bovine adrenal chromaffin cells. Neuron 1996; 16:1027-36
32. Currie KP, Fox AP: Comparison of N-and P/Q-type voltagegated calcium channel current inhibition. J Neurosci 1997; 17:4570-9
33. Catterall WA: Structure and regulation of voltage-gated Ca2+ channels. Annu Rev Cell Dev Biol 2000; 16:521-55
34. Stotz SC, Zamponi GW: Structural determinants of fast inactivation of high voltage-activated Ca(2+) channels. Trends Neurosci 2001; 24:176-81
35. Cox DH, Dunlap K: Inactivation of N-type calcium current in chick sensory neurons: Calcium and voltage dependence. J Gen Physiol 1994; 104:311-36
36. Lee A, Wong ST, Gallagher D, Li B, Storm DR, Scheuer T, Catterall WA: Ca2 +calmodulin binds to and modulates P/Qtype calcium channels. Nature 1999; 399:155-9
37. Liang H, DeMaria CD, Erickson MG, Mori MX, Alseikhan BA, Yue DT: Unified mechanisms of Ca2+ regulation across the Ca2+ channel family. Neuron 2003; 39:951-60
38. McDavid S, Currie KP: G-proteins modulate cumulative inactivation of N-type (Cav2.2) calcium channels. J Neurosci 2006; 26:13373-83
39. Machado JD, Gómez JF, Betancor G, Camacho M, Brioso MA, Borges R: Hydralazine reduces the quantal size of secretory events by displacement of catecholamines from adrenomedullary chromaffin secretory vesicles. Circ Res 2002; 91:830-6
40. Montesinos MS, Camacho M, Machado JD, Viveros OH, Beltrán B, Borges R: The quantal secretion of catecholamines is impaired by the accumulation of beta-adrenoceptor antagonists into chromaffin cell vesicles. Br J Pharmacol 2010; 159:1548-56
41. Mao YF, Liu XR, Liao XZ, Lv YH, Xu H, Deng XM, Yan SK, Xiong YC, Zhang WD: Blood serum profiling of the rat spinal nerve ligation model using ultra-performance liquid chromatography-quadruple time-of-flight mass spectrometry. Eur J Pharmacol 2009; 615:61-5
42. Takeuchi Y, Takasu K, Honda M, Ono H, Tanabe M: Neurochemical evidence that supraspinally administered gabapentin activates the descending noradrenergic system after peripheral nerve injury. Eur J Pharmacol 2007; 556:69-74
43. Hayashida K, DeGoes S, Curry R, Eisenach JC: Gabapentin activates spinal noradrenergic activity in rats and humans and reduces hypersensitivity after surgery. ANESTHESIOLOGY 2007; 106:557-62
44. Takasu K, Ono H, Tanabe M: Gabapentin produces PKAdependent pre-synaptic inhibition of GABAergic synaptic transmission in LC neurons following partial nerve injury in mice. J Neurochem 2008; 105:933-42
45. Hayashida K, Obata H, Nakajima K, Eisenach JC: Gabapentin acts within the locus coeruleus to alleviate neuropathic pain. ANESTHESIOLOGY 2008; 109:1077-84
46. Fink K, Meder W, Dooley DJ, Göthert M: Inhibition of neuronal Ca(2+) influx by gabapentin and subsequent reduction of neurotransmitter release from rat neocortical slices. Br J Pharmacol 2000; 130:900-6
47. McClelland D, Evans RM, Barkworth L, Martin DJ, Scott RH: A study comparing the actions of gabapentin and pregabalin on the electrophysiological properties of cultured DRG neurones from neonatal rats. BMC Pharmacol 2004; 4:14
48. Yoon EJ, Hamm HE, Currie KP: G protein betagamma subunits modulate the number and nature of exocytotic fusion events in adrenal chromaffin cells independent of calcium entry. J Neurophysiol 2008; 100:2929-39
49. Marcantoni A, Carabelli V, Vandael DH, Comunanza V, Carbone E: PDE type-4 inhibition increases L-type Ca(2+) currents, action potential firing, and quantal size of exocytosis in mouse chromaffin cells. Pflugers Arch 2009; 457:1093-110
50. Fulop T, Smith C: Physiological stimulation regulates the exocytic mode through calcium activation of protein kinase C in mouse chromaffin cells. Biochem J 2006; 399:111-9
51. Machado JD, Segura F, Brioso MA, Borges R: Nitric oxide modulates a late step of exocytosis. J Biol Chem 2000; 275:20274-9
52. Graham ME, Fisher RJ, Burgoyne RD: Measurement of exocytosis by amperometry in adrenal chromaffin cells: Effects of clostridial neurotoxins and activation of protein kinase C on fusion pore kinetics. Biochimie 2000; 82:469-79
53. Machado JD, Morales A, Gomez JF, Borges R: cAmp modulates exocytotic kinetics and increases quantal size in chromaffin cells. Mol Pharmacol 2001; 60:514-20
54. Zhao B, Wang HB, Lu YJ, Hu JW, Bao L, Zhang X: Transport of receptors, receptor signaling complexes and ion channels via neuropeptide-secretory vesicles. Cell Res 2011; 21:741-53
55. Misra S, Koshy T, Unnikrishnan KP, Suneel PR, Chatterjee N: Gabapentin premedication decreases the hemodynamic response to skull pin insertion in patients undergoing craniotomy. J Neurosurg Anesthesiol 2011; 23:110-7
56. Kovac AL: Controlling the hemodynamic response to laryngoscopy and endotracheal intubation. J Clin Anesth 1996; 8:63-79
57. Charlesworth P, Pocock G, Richards CD: Calcium channel currents in bovine adrenal chromaffin cells and their modulation by anaesthetic agents. J Physiol 1994; 481(Pt 3):543-53
58. Xie Z, Currie KP, Fox AP: Etomidate elevates intracellular calcium levels and promotes catecholamine secretion in bovine chromaffin cells. J Physiol 2004; 560:677-90
59. Herring BE, McMillan K, Pike CM, Marks J, Fox AP, Xie Z: Etomidate and propofol inhibit the neurotransmitter release machinery at different sites. J Physiol 2011; 589:1103-15
60. Herring BE, Xie Z, Marks J, Fox AP: Isoflurane inhibits the neurotransmitter release machinery. J Neurophysiol 2009; 102:1265-73
61. Bannister JP, Adebiyi A, Zhao G, Narayanan D, Thomas CM, Feng JY, Jaggar JH: Smooth muscle cell alpha2delta-1 subunits are essential for vasoregulation by CaV1.2 channels. Circ Res 2009; 105:948-55
62. Alden KJ, Garcia J: Differential effect of gabapentin on neuronal and muscle calcium currents. J Pharmacol Exp Ther 2001; 297:727-35
63. Carroll I, Mackey S, Gaeta R: The role of adrenergic receptors and pain: The good, the bad, and the unknown. Sem Anes Periop Pain 2007; 26:17-21
64. Kim SH, Na HS, Sheen K, Chung JM: Effects of sympathectomy on a rat model of peripheral neuropathy. Pain 1993; 55:85-92
65. Treede RD, Davis KD, Campbell JN, Raja SN: The plasticity of cutaneous hyperalgesia during sympathetic ganglion blockade in patients with neuropathic pain. Brain 1992; 115(Pt 2):607-21